Cancer biotech TwoStep gets $62.5M to take twist on ADCs into clinic

Pfizer and Merck KGaA's venture groups are backing a nimble cancer startup taking a different approach to the popular antibody-drug conjugate and radioligand fields. TwoStep Therapeutics collected $62.5 million in a Series A raise to ...